Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2003
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038057A2 Genetic vaccine against human immunodeficiency virus
05/08/2003WO2003038055A2 Proteins involved in regulation of adipocytes and uses related thereto
05/08/2003WO2003038054A2 Structure-based design and synthesis of fgf inhibitors and fgf modulator compounds
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038051A2 Method of inducing apoptosis in hyperproliferative cells
05/08/2003WO2003038050A2 Antisense modulation of phospholipase a2 group v expression
05/08/2003WO2003038047A2 Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003038040A2 32235, a human aminotransferase family member and uses therefor
05/08/2003WO2003038038A2 16 human secreted proteins
05/08/2003WO2003038037A2 Glycogen synthase kinase function in endothelial cells
05/08/2003WO2003038036A2 Rescue of gonadotropin releasing hormone receptor mutants
05/08/2003WO2003038034A2 Calcitonin-like sequence expressed by gonadotropes of the anterior pituitary
05/08/2003WO2003038032A2 Means for inhibition of the synthesis of viral proteins
05/08/2003WO2003037933A2 Dermopharmaceutically and cosmetically active oligopeptides
05/08/2003WO2003037932A2 Human coagulation factor vii polypeptides
05/08/2003WO2003037931A2 Human angiomotin-like protein 1
05/08/2003WO2003037928A2 Analogs of human growth hormone-releasing hormone, their preparation and use
05/08/2003WO2003037922A1 Analgesic antitumor peptide from scorpion and method of producing it
05/08/2003WO2003037920A2 Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration
05/08/2003WO2003037917A1 Tumor antigen
05/08/2003WO2003037916A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/08/2003WO2003037915A1 Biocompatible polymers including peptide spacer
05/08/2003WO2003037912A2 Tri-, tetra-, and penta-peptides having antiangiogenic activity
05/08/2003WO2003037908A1 Antiviral combination therapy and compositions
05/08/2003WO2003037830A2 Photoactivatable composition and the use of same
05/08/2003WO2003037400A2 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/08/2003WO2003037378A1 Method of preventing development of severe metabolic derangement in inborn errors of metabolism
05/08/2003WO2003037377A1 Preventives/remedies for proliferative organ diseases, chronic arthritic diseases, hypertrophic scar or keloid
05/08/2003WO2003037376A1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
05/08/2003WO2003037374A1 Method of treatment of vulval vestibulitis
05/08/2003WO2003037368A2 Smad7 inhibitors for the treatment of cns diseases
05/08/2003WO2003037366A1 Method of administering a thymosin alpha 1 peptide
05/08/2003WO2003037365A1 Methods and compositions for treating vascular leak using hepatocyte growth factor
05/08/2003WO2003037364A1 Interleukin-18 inducing agent
05/08/2003WO2003037363A2 Non-neurotoxic plasminogen activating factors for treating stroke
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037356A1 Pharmaceutical preparation comprising a growth factor and/or a cytokine and an antiseptic biguanide
05/08/2003WO2003037348A1 Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of dysmenorrhea and menorrhagia
05/08/2003WO2003037322A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
05/08/2003WO2003037320A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003WO2003037299A1 Novel formulation
05/08/2003WO2003037296A2 Methods and dosage forms for improving the bioavailability of therapeutic agents
05/08/2003WO2003037273A2 Method of use of erythropoietin to treat ischemic acute renal failure
05/08/2003WO2003037272A2 Thymosin alpha 1 peptide/polymer conjugates
05/08/2003WO2003037269A2 Di-, tri,- and tetra-peptides having antiangiogenic activity
05/08/2003WO2003037268A2 Hepta-, octa- and nonapeptides having antiangiogenic activity
05/08/2003WO2003037267A2 Compositions and methods for the therapy and diagnosis of lung cancer
05/08/2003WO2003037266A2 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
05/08/2003WO2003037265A2 Method of treating viral infections
05/08/2003WO2003037261A2 Methods and compositions for the treatment and diagnosis of pain disorders using 9805
05/08/2003WO2003037260A2 Methods and compositions for treating parkinson's disease
05/08/2003WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/08/2003WO2003037256A2 Use of somatostatin receptor agonists in the treatment of human disorders of sleep hypoxia and oxygen deprivation
05/08/2003WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
05/08/2003WO2003037253A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
05/08/2003WO2003037249A2 Method for inhibiting the formation of seromas using factor xiii
05/08/2003WO2003037248A2 Fibrin nanoparticles and uses thereof
05/08/2003WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy
05/08/2003WO2003037167A2 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
05/08/2003WO2003037166A2 Devices and methods for the restoration of a spinal disc
05/08/2003WO2003037165A2 System and method for the pretreatment of the endplates of an intervertebral disc
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003037060A2 Compositions and methods for wt1 specific immunotherapy
05/08/2003WO2003028001A8 Method and pharmaceutical composition for inducing cancer cell-specific apoptosis by combination with tnf family proteins and flavopiridol
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003006067A3 Composition comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis
05/08/2003WO2003004691A3 Regulators of biofilm formation and uses thereof
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2003000633A3 A process for the isolation of a major harmful oxidant from cigarette smoke
05/08/2003WO2003000027A3 Blocking peptide for inflammatory cell secretion
05/08/2003WO2002098908A3 Osteoclastogenesis inhibitory factor, sequence coding for it and uses
05/08/2003WO2002098482A3 System for osmotic delivery of pharmaceutically active agents
05/08/2003WO2002098286A3 Implantation of biological pacemaker that is molecularly determined
05/08/2003WO2002097114A3 Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
05/08/2003WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
05/08/2003WO2002090524A3 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
05/08/2003WO2002083076A3 Method for inhibiting atherosclerotic plaque formation
05/08/2003WO2002081499A3 Somatostatin agonists
05/08/2003WO2002079230A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002064129A3 Compositions of biochemical compounds involved in bioenergy metabolism of cells
05/08/2003WO2002057299A3 Vegfr-3 binding peptides and their use for inhibiting angiogenesis
05/08/2003WO2002044356A3 25206, a novel human short-chain dehydrogenase/reductase family member and uses thereof
05/08/2003WO2002028405A3 Method for inducing onset of the reproductive cycle of female breeding animals
05/08/2003WO2002026946A3 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
05/08/2003WO2002024929A3 A SOLUBLE BETA 2 MICROGLOBULIN (β2M)/HFE MONOCHAIN FOR BIOTECHNOLOGICAL AND THERAPEUTIC APPLICATIONS
05/08/2003WO2002020768A9 Caveolin peptides and their use as therapeutics
05/08/2003WO2002018552A8 Regulation of human aminotransferase-like enzyme
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001081378A3 G-protein coupled receptors
05/08/2003WO2001057274A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
05/08/2003US20030088884 Orphan leucine-repeat-containing, G protein-coupled receptors; prevention or induction of labor, treatment scleroderma, cryptorchidism, and diagnosis of a genetic condition associated LGR8 or LGR7
05/08/2003US20030088087 Purification of preferential nucleotide sequences; obtain nucleotide sequences, load onto column, elute, deprotect, load deprotected mixture onto column, elute and recover sequences
05/08/2003US20030088085 MPROT12 polynucleotides and methods thereof
05/08/2003US20030088084 Novel human zinc-binding proteins
05/08/2003US20030088078 Nucleotide sequences coding polypeptide for use in the treatment of brain and nervous system disorders
1 ... 1849 1850 1851 1852 1853 1854 1855 1856 1857 1858 1859 1860 1861 1862 1863 1864 1865 1866 1867 1868 1869 ... 3163